全部

1·To prove the lung adenocarcinoma cells oncogenic capability in vitro.

并初步证实肺腺癌细胞体外致瘤能力的差异性。

2·Objective To establish a multidrug resistance cell line from human lung adenocarcinoma.

目的建立人肺腺癌多药耐药细胞系。

3·Objective To research an effective therapy method for advanced lung adenocarcinoma cases.

目的探讨治疗晚期肺腺癌的有效方法。

4·To investigate the suppression effect of tumor suppressor gene in lung adenocarcinoma cells.

探讨肿瘤抑制基因对肺腺癌细胞生长的抑制作用。

5·Conclusion: DTA gene regulated by tetracycline has therapeutic effects on lung adenocarcinoma.

结论：四环素调控白喉毒素A基因对肺腺癌有一定的治疗作用。

6·SLAK levels were highest in lung adenocarcinoma patients with distant metastasis, the results indicate.

研究结果表明，在肺腺癌伴有远处转移的病人中SLAK水平最高。

7·Objective To study the correlation between tumor markers and CT characteristics of lung adenocarcinoma.

目的 探讨肺腺癌CT 征象与肿瘤标记物的关系。

8·The fourth patient presented with paraneoplastic cerebellar degeneration antedating a lung adenocarcinoma.

另外一例副肿瘤综合症患者表现为早于肺腺癌的副肿瘤性小脑变性。

9·Objective: To investigate the effect and mechanism of insulin on human lung adenocarcinoma cell strain A549.

目的：探讨用胰岛素提高人肺腺癌细胞A549生长代谢水平及其机制。

10·Objective To study the effect of MVP chemotherapy combined with radiotherapy for advanced lung adenocarcinoma.

目的探讨化疗联合放疗对晚期肺腺癌预后的影响。